Thursday 24 March
09:00-11:15
Session 3: iPSC- and stem cell-based cell therapies
Chairs: Thomas Moritz, Hannover Medical School; Tobias Cantz, Hannover Medical School
09:00-09:15 Thomas Moritz, Hannover Medical School; Tobias Cantz, Hannover Medical School
iPSC and stem cell-based therapies – current status in a nutshell
INV08 09:15-09:45
Ulrich Martin, Hannover Medical School ⓘ
hiPS cells for clinical heart repair: Generation of GMP-compliant cell lines, large scale cardiomyocyte production and preclinical evaluation in a non-human primate model
INV09 09:45-10:15
Miguel Esteban, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences
Single stem cells
INV10 10:15-10:45
Claire Booth, University College London ⓘ
Stem cell gene therapy for immune deficiencies; new approaches to correction
OR05 10:45-11:00
Daniela Paasch, Hannover Medical School
A universal platform to generate chimeric antigen receptor macrophages from human stem cell sources
OR06 11:00-11:15
Masako Monica Kaufmann, Medical Center – University of Freiburg
Universal CAST-Seq: Target sequence-independent detection of CRISPR-Cas off-target effects in primary human stem cells